|Articles|September 1, 2003
CXRs offer 'Limited Value' for Melanoma
Author(s)Beth Kapes
Chicago - A recent review of routine chest X-rays for pulmonary metastasis adds weight to a growing body of evidence that CXRs have limited value in the follow-up of melanoma patients and their prolonged survival.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5










